GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genova 9341.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

571

+1.96%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥11.57bn

FY2021FY2026

Net income

¥275.4m

FY2021FY2026

Free cash flow

−¥47.0m

FY2021FY2026

Shareholders' equity

¥6.90bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue¥11.57bn¥10.01bn¥8.68bn¥6.51bn¥4.80bn¥3.77bn
Gross profit¥6.47bn¥7.38bn¥6.55bn¥4.79bn¥3.50bn¥2.63bn
Research and development—¥151.1m¥46.9m¥29.2m¥33.7m¥46.4m
Operating income¥400.4m¥2.03bn¥2.30bn¥1.73bn¥1.06bn¥801.8m
Net income¥275.4m¥1.41bn¥1.73bn¥1.26bn¥686.3m¥629.4m
Diluted earnings per share15.8780.9095.8970.3640.5836.28

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets¥10.26bn¥8.53bn¥8.20bn¥5.41bn¥2.82bn¥1.87bn
Cash and short-term investments¥5.32bn¥5.87bn¥5.97bn¥3.86bn¥1.65bn¥1.17bn
Total liabilities¥3.36bn¥1.53bn¥2.16bn¥1.37bn¥1.33bn¥1.10bn
Debt¥735.7m¥20.8m¥377.8m¥28.2m¥163.5m¥133.4m
Shareholders' equity¥6.90bn¥7.00bn¥6.04bn¥4.04bn¥1.49bn¥768.3m
Shares outstanding17m17m18m18m17m17m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations¥53.9m¥1.19bn¥1.82bn¥1.20bn¥623.8m¥1.06bn
Capital spending−¥100.8m−¥135.9m−¥57.0m−¥91.7m−¥110.4m−¥16.7m
Free cash flow−¥47.0m¥1.06bn¥1.77bn¥1.11bn¥513.4m¥1.04bn
Dividends paid−¥519.2m—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥3.06bn¥3.64bn¥2.96bn¥3.12bn¥1.86bn¥2.39bn¥2.47bn¥2.61bn
Gross profit¥1.53bn¥2.02bn¥1.48bn¥1.72bn¥1.24bn¥1.74bn¥1.78bn¥1.97bn
Operating income−¥222.2m¥424.0m¥13.2m¥137.7m−¥174.5m¥399.7m¥408.7m¥626.6m
Net income¥249.8m¥224.6m¥64.7m¥84.3m−¥98.3m¥327.4m¥271.2m¥430.3m
Diluted earnings per share14.4012.953.704.83-5.6218.7415.0623.89
Total assets¥11.31bn¥10.26bn¥9.89bn¥9.97bn¥7.58bn¥8.53bn¥8.63bn¥8.59bn
Cash and short-term investments¥5.08bn¥5.32bn¥5.26bn¥5.36bn¥5.18bn¥5.87bn¥6.08bn¥5.99bn
Debt¥383.4m¥735.7m¥117.7m¥794.6m¥8.3m¥20.8m¥33.3m¥45.8m
Shareholders' equity¥6.15bn¥6.90bn¥6.64bn¥6.54bn¥6.41bn¥7.00bn¥7.20bn¥6.94bn

Financial ratios

Data as of 5 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin55.9%73.7%75.5%73.5%72.8%69.8%
Operating margin3.5%20.2%26.5%26.6%22.0%21.3%
Net margin2.4%14.1%19.9%19.3%14.3%16.7%
Return on equity4.0%20.2%28.6%31.2%46.2%81.9%
Return on assets2.7%16.6%21.1%23.3%24.3%33.6%
Free cash flow yield1.5%12.5%17.1%11.9%7.1%—
Revenue growth15.6%15.2%33.3%35.6%27.4%—
Earnings growth-80.5%-18.1%37.0%83.6%9.0%—
Current ratio3.73x5.19x3.58x3.73x1.98x1.57x
Debt to equity0.11x0.00x0.06x0.01x0.11x0.16x
Equity ratio67.3%82.1%73.6%74.6%52.7%41.0%
Interest coverage76.32x3822.89x4146.80x1140.00x491.08x308.75x
R&D as a share of sales—1.5%0.5%0.4%0.7%1.2%
Buybacks as a share of market value0.7%3.0%-0.5%-5.9%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.1%25.1%—
Operating income-38.7%-13.0%—
Net income-39.8%-15.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin64.2%68.5%69.1%—
Operating margin11.2%17.6%18.4%—
Net margin7.8%12.7%13.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings35.87.213.723.041.2
Price to sales0.81.02.74.45.9

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 30 Mar 2026.

FY2026
Paid in the year40.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.